News

Immunoglobulin light chain (AL) amyloidosis is a rare and potentiallylife‐threatening disorder characterized by the deposition ofmisfolded, toxic immunoglobulin…

Biology of sex differencesBiol Sex Differ. 2026 Feb 17. doi: 10.1186/s13293-025-00800-w. Online ahead of print.ABSTRACTAlzheimer's disease (AD) is a progressive…

(WISH) — Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and nervous system.AdventHealth says…

Like Parkinson’s disease, ATTR-CM is caused by a buildup of misfolded proteins. In this case, the culprit is transthyretin. Under normal conditions, transthyretin…

Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) may be associated with a reduced risk of Alzheimer disease, according to the preprint of a large…

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis.For patients…

JACC: Case Reports is seeking high-impact case reports that advance clinical understanding of cardiac amyloidosis, encouraging submissions that showcase diagnostic…

AbstractBackground: Carpal tunnel syndrome (CTS) has been recognized as a potential early manifestation of systemic amyloidosis; however, its prognostic…

Alzheimers Res Ther. 2026 Feb 14. doi: 10.1186/s13195-026-01974-0. Online ahead of print.ABSTRACTBACKGROUND: Plasma biomarkers have emerged as robust indicators of…

Market OverviewThe Transthyretin amyloid cardiomyopathy (ATTR-CM) was valued at US$ 2.92 Billion n 2023. The global transthyretin amyloid cardiomyopathy (ATTR-CM)…